- Home
- NLSP vs TSI Comparison
NLSP vs TSI Comparison
Compare NLSP & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- TSI
- Stock Information
- Founded
- NLSP 2015
- TSI 1987
- Country
- NLSP Switzerland
- TSI United States
- Employees
- NLSP N/A
- TSI N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- NLSP Health Care
- TSI Finance
- Exchange
- NLSP Nasdaq
- TSI Nasdaq
- Market Cap
- NLSP 12.4M
- TSI 236.5M
- IPO Year
- NLSP 2021
- TSI N/A
- Fundamental
- Price
- NLSP $2.06
- TSI $5.02
- Analyst Decision
- NLSP
- TSI
- Analyst Count
- NLSP 0
- TSI 0
- Target Price
- NLSP N/A
- TSI N/A
- AVG Volume (30 Days)
- NLSP 204.8K
- TSI 106.8K
- Earning Date
- NLSP 10-17-2025
- TSI 01-01-0001
- Dividend Yield
- NLSP N/A
- TSI 7.46%
- EPS Growth
- NLSP N/A
- TSI N/A
- EPS
- NLSP N/A
- TSI N/A
- Revenue
- NLSP N/A
- TSI N/A
- Revenue This Year
- NLSP N/A
- TSI N/A
- Revenue Next Year
- NLSP N/A
- TSI N/A
- P/E Ratio
- NLSP N/A
- TSI N/A
- Revenue Growth
- NLSP N/A
- TSI N/A
- 52 Week Low
- NLSP $1.30
- TSI $4.48
- 52 Week High
- NLSP $6.97
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- NLSP 45.09
- TSI 71.86
- Support Level
- NLSP $1.88
- TSI $4.96
- Resistance Level
- NLSP $2.29
- TSI $5.00
- Average True Range (ATR)
- NLSP 0.13
- TSI 0.03
- MACD
- NLSP -0.00
- TSI 0.00
- Stochastic Oscillator
- NLSP 53.61
- TSI 85.00
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.